Darvish Nissim
Insider CIK 1793602 · CMMB Director · NMTR Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2023-06-14 | 2023-07-05 | 20,572 | — | $0 | 20,572 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2023-03-16 | 2023-07-05 | 6,857 | — | $0 | 6,857 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2023-03-16 | 2023-03-23 | 6,857 | — | $0 | 6,857 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | P Buy | 2022-03-11 | 2022-03-14 | 1,200 | $4.28 | $5.1K | 1,200 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2023-07-05 | 6,820 | — | $0 | 6,820 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2023-03-23 | 6,820 | — | $0 | 6,820 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2022-03-09 | 6,820 | — | $0 | 6,820 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2022-03-07 | 2022-03-14 | 6,820 | — | $0 | 6,820 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2023-07-05 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2023-03-23 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2022-03-09 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2022-03-14 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2021-04-21 | 11,884 | — | $0 | 11,884 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-03-16 | 2022-03-14 | 10,123 | — | $0 | 10,123 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | J Other | 2020-10-30 | 2020-11-03 | 1,943,734 | — | $0 | 25,716,755 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | A Award deriv | 2020-07-06 | 2020-07-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 67,865 | — | $0 | 0 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | C Conversion | 2020-06-30 | 2020-07-02 | 6,786,500 | — | $0 | 23,773,021 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | P Buy deriv | 2020-05-04 | 2020-05-05 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | P Buy deriv | 2020-05-04 | 2020-05-05 | 67,865 | — | $0 | 6,786,500 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | A Award deriv | 2020-04-30 | 2020-05-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2016-10-28 | 2023-07-05 | 10,123 | — | $0 | 10,123 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2016-10-28 | 2023-03-23 | 10,123 | — | $0 | 10,123 | SEC↗ |